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The effectiveness of Co(I1)-DTPA and Zn(I1)-DTPA in preventing 
the retention of radiocerium and radioyttrium by the organs of the rat was 
studied and found to be insignificantly diminished as compared with 
Ca-DTPA. The therapeutic index of both chelates, on the other hand, is 
greater than that of Ca-DTPA because of their low toxicity. The possible 
therapeutic use of these chelates is discussed. 
The  calcium-chelate of diethylenetriaminepentaacetic acid (DTPX)  has 
proven to be a valuable antidote in poisoning with radioactive or stable metals 
(for detailed bibliography see Catsch 1964a). The  toxicity of C a - D T P 4  is 
markedly higher than that of Co(I1)- and Zn(I1)-DTP-1 (Catsch 1964b). 
This is in keeping with earlier observations with ethylenediaminetetraacetic 
acid (Steffensen 1957, Sullivan 1960). I t  may be assumed tentatively that 
the reduced tosicity of the more stable chelates, i.e. Co(I1)- and Zn(I1)-DTPA, 
is due to the fact that the chelated exogenous metals are exchanged, if at all, 
to  a lesser extent against essential endogenous metal ions than it is the case with 
Ca-DTI'A. 
Provided that Co(I1)- and Zn(I1)-DTP-4 do not suffer a marked loss in 
the therapeutic efficacy, i.e. of their ability in mobilizing tosic metals from 
the body, their therapeutic index (defined as the ratio of tosic to therapeutic 
doses) should surpass that of Ca-DTPA. The  resulting practical implications 
are obvious. T h e  present study is concerned with the comparison of the 
DTPS-chelates referred to above in lowering the retention of radiocerium and 
radioyttrium by the organs of the rat. 
T h e  animals used \\,ere male rats from the Heiligenberg-strain, 'I to 15 weeks 
old. Carrier-free 14JCe(III) or 911'(111) was injected intravenously as chloride 
(3 to 5 pc per animal). T h e  following chelates were used : ( i )  Xa3Ca-DTPX, 
(ii) Ka3Co-DTPX (excess of free D T P A  6 0.5 per cent), and (iii) ?;a,Zn-DTP-4 
(excess of free DTP--1,< 0.2 per cent). Different dosages of these chelates were 
administered either intravenously and simultaneously with l"Ce or intra- 
peritoneally on the 2nd, 5th and 8th day following the injection of l4%e and 
"Y, respectively. In  the former experiment, the animals were sacrificed 48 
hours after the administration of 14Te,  in the latter series-on the 12th day. 
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The activity of the ashed organs was assayed by means of an end-window 
counter. The radionuclide content of the skeleton was assumed to be 20 times 
that of a femur. In the experiments where Co(I1)- and Zn(I1)-DTPA labelled 
by G°Co and G5Zn, respectively, were used, the retention of the radionuclide 
was determined by in vivo whole-body counting; a plastic scintillator (NE 102; 
7 in. diameter, 5 in. deep) was used. 
3. RESULTS 
The maximal effect of the metal chelates is obtained with simultaneous 
administration. The results of this series are shown in figures 1 to 3, the 
144Ce-content of the organs being expressed as percentage of the average of 
20 untreated animals. I n  the control group, liver, skeleton and kidneys retained 
Figure 1. Retention of I4Te  by the liver as influenced by different doses (pM per animal) 
of DTPA-chelates. DTPA was administered simuItaneously with 144Ce. Each 
point is the average of 6 to 10 rats ; the vertical bars indicate fiducial limits (P = 0.05). 
35.8, 33-7 and 2-32 per cent, respectively, of the administered 14Te-amount. 
I n  no case was a linear dependence of effectiveness upon dosage obtained. On 
the other hand, the shape of the dose-effect-curves is obviously identical for 
all three chelates. There is no  significant difference in the efficacy of Ca- and 
Zn(I1)-DTPA while the effectiveness of Co(I1)-DTPA is apparently reduced 
as compared with Ca-DTPA. 
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Figure 2 .  Retention of 14"e by the skeleton as influenced by different doses (pM per 
animal) of DTPA-chelates. DTPA was administered simultaneoulsy with 144Ce. 
Each point is the average of 6 to 10 rats ; the vertical bars indicate fiducial limits 
(P= 0.05). 
Figure 3. Retention of * W e  by the kidneys as influenced by different doses (phi per 
animal) of DTPA-chelates. DTPA was administered simultaneously with 14*Ce. 
Each point is the average of 6 to 10 rats ; the vertical bars indicate fiducial limits 
(P= 0.05). 
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In  the experimental series where the chelates were given with a delay and 
the activity of the organs was assayed on the 12th day, the liver in the control 
group (23 rats) retained 15.0 per cent of the 'We-dose, the kidneys--0.61 per 
cent. Although it is known that there is no elimination of 144Ce from the bones, 
the skeletal content in the control group (18.5 per cent) was lower than in the 
preceding experiment. This is due to the different age of the animals in both 
experiments, a factor which exerts a significant influence on the skeletal retention 
(Schmautz 1964). In the glY-control group (27 animals), liver, skeleton and 
kidneys retained 0.95, 64.8 and 1-32 per cent respectively. 
I n  all cases, parallel dose-effect curves were obtained so that (after omission 
of the lowest dosages in the 14Te-series which deviate distinctly from a linear 
regression) the relative potency of Ca-DTPA could be calculated (cf. Finney 
1952). The relative potency p indicates the factor by which the effectiveness 
of Ca-DTPA is higher than that of Co(1I)- and Zn(I1)-DTPA. Dividing 
the actual dosages of the last mentioned chelates by the p-values listed in the 
table, all experimental points can be satisfactorily fitted by the common dose- 
effect curves presented in figures 4 and 5. 
Figure 4. Retention of 14Te  by the organs as influenced by different doses of DTPA- 
chelates. DTPA was administered on the 2nd, 5th and 8th day. The actual 
doses of Zn(I1)- and Co(I1)-DTPA are divided by the p-values listed in the table. 
Each point is the average of 10 rats. 
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The retention of 60Co and 65Zn after a single or repeated administration of 
labelled Co(I1)- and Zn(I1)-DTPA, respectively, is sho\vn in figures 6 and 7. 
Using the data obtained in the single exposure study, the expected retention of 
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multiple doses was calculated for the 11th day. Whereas the predicted build-up 
of 60Co (0.3 per cent) agrees satisfactorily with the actually observed 0.22 per cent, 
the retention of multiple 052x1-doses(2 per cent) is lower than the expected 
(5 per cent). 
" r Na,Ca-DTPA 




Figure 5 .  Retention of glY by the organs as influenced by different doses of DTPA- 
chelates. DTPA was administered on the 2nd, 5th and 8th day. The actual 
doses of Zn(I1)- and Co(l1)-DTPA are divided by the p-values listed in the table. 
Each point is the average of 10 rats. 
Potency (p) of Ca-DTPA reIative to Co(I1)-DTPA &uld Zn(I1)-DPT-A. The figures in 
brackets indicate the fiducial limits (P=O.O5). For further esplanation see test. 
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4. DISCUSSION 
Extending the semiquantitative treatment by Heller and Catsch (1959), 
the effectiveness of any metal-chelate J l L  in removing a carrier-free radiometal 
"M from the body, in a first approximation, should be proportionately related to: 
K:::, . (L)totnl 
M + K&. (Ca) + K&, . (M) ' 
K are the stability constants of the corresponding 1 : l-chelates, the brackets 
indicate concentrations, and the influence of PH is taken into account by the 
distribution coefficient a (Heller and Catsch 1959). I t  can be reasonably 
assumed that (Ca), (CO) and (Zn) in the mammalian organism are virtually 
invariable. The log-values of the stability constant of Co(11)- and Zn(I1j- 
DTPA are 19.27 and 18-55, respectively, whereas K:;, equals 10.89 (Anderegg, 
Nageli, Miiller and Schwarzenbach 1959). Since the effectiveness of all three 
chelates lies within the same order of magnitude, it may be concluded that 
K,$:,. (CO) as well as K;:, . (Zn) do not differ significantly from K g L .  (Ca). 
This implies necessarily that (CO) and (Zn) are negligibly small, even if 
(Co)tOta1 and (Zn)tot,l are raised by the administration of the corresponding 
DTPA-chelate. 
Depending on the organ taken as basis for the calculations, on the kind of 
radionuclide, and, finally, on the time of DTPA-treatment, the determination 
of the relative potency of Ca-DTP,4 yields inconsistent figures (see table and 
figures 1 to 3). The esistent discrepancies cannot be easily explained, if they 
turn out to be real, and additional assumptions would be needed. From the 
practical view-point and taking into account the rather broad fiducial range of 
the relative potencies listed in the table, the apparent differences should by no 
means be overestimated, and it can be stated that there are, if at all, only minor 
differences in the efFicacy of the three chelates. 
For technical reasons, i.e. the limits set up by the solubility of the chelates, 
our earlier studies (Catsch 1964 b) did not succeed in exact evaluation of the 
toxic dosages of Co(11)- and Zn(I1)-DTPA. I t  could be stated only that in 
chronic toxicity tests Zn(I1)-DTPA is at least ten times, and Co(I1)-DTPA 
about four times less toxic than Ca-DTPA. If a p-value of 2 for 
Ca-DTPAIZn(I1)-DTPh (after averaging the figures of the table) is assumed, 
it follows that the therapeutic index of Zn(I1)-DTPA is at least five times higher 
than that of Ca-DTP-4. TTTith Co(I1)-DTPA, the increase of the therapeutic 
index is less pronounced. 
So far, no data are available for the mobilization by Zn(1I)- and Co(11)-DTPA 
of other practically important metal ions, such as Pb, Fe or 23Tu. It is fairly 
unlikely, however, that relative potencies would be obtained fundamentally 
different from lUCe and "Y. 
The non-linear relationship between dosage and effect which was demon- 
strated with simultaneous administration of the chelators (see figures 1 to 3) 
suggests a 'compartmentalization ' of the given organ, i.e. the organ has to be 
conceived as composed of several compartments, each of which is characterized 
by different affinities toward the radiometal and, therefore, by differing response 
to the chelator (Catsch 1961, 1964a). Delayed administration of the chelator 
(see figures 4 and 5) is followed by a pronounced loss in effectiveness as well as 
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by a marked change of the shape of the dose-effect curves. Obviously, the bulk 
of the radiometal becomes transferred from the loosely bound state into the 
compartment(s) with a more stable binding. It is not at all unexpected that 
different radiometals, such as radiocerium and radioyttrium, behave in this 
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Figure 6. Whole-body retention of =OCo administered intraperitoneally as DTPA-chelate. 
In the case of multiple doses, the percentage refers to the total dose. Each point 
is the average of 3 rats. 
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Figure 7. Khole-body retention of 65Zn adn~inistered intraperltoneally as DTP-l-chelate. 
In thc case of multiple doses, the percentage refers to the total dose. Each point 
is the average of 3 rats. 
respect quite individually. The  relatively easy mobilization of l"Ce from the 
liver is in sharp contrast to other tissues as \\-ell as to the response of 'IT. 
Pertinent to the follov-ing considerations is the relath-el! small slope of the 
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dose-effect curves. This is in keeping with analogous findings of Catsch and 
Seidel (1963), Norwood (1962), Rosoff, Ritter, Sullivan, Hart and Spencer- 
Laszlo (1961), Schubert, Fried, Rosenthal and Linderibaum (1961), Taylor 
and Sowby (1962). 
The greater therapeutic index of Co(I1)- and, in particular, of Zn(I1)-DTPA 
makes a higher dosage than with Ca-DTPA feasible. However, if the small 
slope of the dose-effect curves is taken into account, the actual gain in therapeutic 
effectiveness will remain insignificant. Therefore, the sole, though essential, 
advantage offered by the less toxic chelates is the gain of an increased safety. 
Taking into account that the toxicity of Zn(I1)-DTPA, for instance, is at least 
ten times, but the effectiveness merely two times lower than that of Ca-DTPA, 
the therapeutic index is increased by a factor of > 1012 = > 5. 
For the related ethylenediaminetetraacetic acid a dosage of 0.12 mM per 
kilogram and per day is generally recommended for humans (e.g. Foreman, 
Finnegan and Lushbaugh 1956, Seven 1960). Because of the two times higher 
toxicity of DTPA (Catsch 1964b), the dosage should be reduced to O.06mM 
Ca-DTPA per kilogram and per day. With Co(I1)- and Zn(I1)-DTPA 
(allowing for their possibly slightly reduced efficacy) a dosage of 0.15 mM 
per kilogram and per day may tentatively be considered as appropriate. 
Before an unrestricted usage of both chelates in humans can be recommended, 
however, a crucial point remains to be settled. Although the repeated admini- 
stration of relatively large doses of Zn(I1)- and Co(I1)-DTPA was not followed 
by lethality and nephrotic damage, there still remains the possibility that other 
and possibly relevant side-effects escaped observation. Referring to the results 
presented in figures 6 and 7, approximately 4 per cent of Zn and 0.7 per cent of 
CO (both administered as chelates) are retained by the body. If the assumption 
is made that these percentages do not depend on the size of the dose, each single 
dose would give rise t-o the splitting-off of approximately 0.3 mg Zn per kilogram 
and 0.05 mg CO per kilogramt. We are not aware of any pertinent investigations 
which prove unequivocally that the repeated (though restricted to a relatively 
short time-period) administration of doses of this order of magnitude leads to 
any harmful side effects. Kevertheless, experiments aiming at the elucidation 
of this question and giving direct evidence are urgently needed. 
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On a Ctudie I'CfficacitC du Co(I1)-DTPA et du Zn(I1)-DTPX h empecher Ia rktention 
du radiockrium et du radioyttrium par les organes du rat. On I'a trouvCe seulement trks 
peu infkrieure h celle du Ca-DTPA. L'index thkrapeutique de ces deux chClates est, 
d'autre part, beaucoup plus tlevk que celui du Ca-DTPA, cn raison de leur faible toxiciti.. 
On va envisager les consCquenccs thCoriques et pratiques de ces rksultats. 
f Recent investigations, as yet uncompleted, indicate that the apparent ' build-up ' 
of 60Co and 65Zn observed in figures G and 7 is caused not by a genuine deposition, but 
mostly by an ordinary exchnrrge between the administered ,and the corresponding 
endogenous metal ions. 
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Der Einflul3 von Co(I1)-DTPA und Zn(I1)-DTPA auf die Verteilung von Radiocer 
und Radioyttrium irn Organismus der Ratte wird untersucht. Die Retentionsverhin- 
d e m g  beider Chelate ist nur unwesentlich kleiner als die von Ca-DTPA. Dagegen ist 
der therapeutische Index beider Chelate weger ihrer geringen Toxicitat xvesentlich hoher 
als bei Ca-DTPA. Die aus den Resultaten sich ergebenden theoretischen und praktischen 
Fragen werden diskutiert. 
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